Sickle Cell Anemia Testing and Screening - Global Market Outlook (2019-2027)
According to Stratistics MRC, the Global Sickle Cell Anemia Testing and Screening Market is accounted for $223.04 million in 2019 and is expected to reach $397.79 million by 2027 growing at a CAGR of 7.5% during the forecast period. Some of the key factors propelling the market growth include increase the uptake of screening products, increasing implementation of strategies to minimize the sickle cell disease burden, rising prevalence of sickle cell disease across the globe. However, infrastructural challenges associated with screening and diagnosis of sickle cell disease is restricting the market growth.
Sickle cell hemoglobin variants are inclusive of HbS, HbA, and HbC. Different tests have been developed to perform a clear distinction between all the three above-mentioned hemoglobin variants. Development of a deep learning framework designed to perform automated screening of sickle cell anemia in blood smear sample of patients via a smartphone microscope is set to open up new avenues for the market in the near future.
By age group, the adult screening segment is expected to grow at the significant rate throughout the forecast period. SCD treatment and management differ at distinct levels based on the patient’s stage. This is attributed to the observed differences in the SCD associated pain, comorbidities, psychosocial impact, and healthcare expenditure with respect to the age group of sickle cell anemia patients. Additionally, increasing number of research activities are aimed at analyzing the impact of age-specific healthcare strategies on improving the management of sickle cell disease population. Employment of targeted screening with respect to age group of sickle cell patients has also extended life span of these patients into adulthood.
On the basis of geography, Asia Pacific region is expected to have considerable market growth during the forecast period. Rising acknowledgment and recognition of sickle cell screening targeted towards newborns have been recently witnessed in the Asia Pacific countries, specifically India. Additionally, these developing countries are devising strategies to address challenges associated with newborn screening programs across high-income countries, which is inclusive of streamlining follow-up screening or diagnosis. This is set to offer a significant momentum to the Asia Pacific market in the near future.
Some of the key players in sickle cell anemia testing and screening market include Request A Test, Ltd., Halcyon Biomedical Incorporated, Silver Lake Research Corporation, Streck, Inc., Daktari Diagnostics, Biomedomics Inc., Laboratory Corporation of America Holdings, PerkinElmer Inc., Quest Diagnostics, Hemotype, Hemex Health, and Bio-Rad Laboratories, Inc.
Age Groups Covered:
• Adult Screening (25 to 60 Years)
• Newborn Screening (12 Months and Below)
• Other Age Groups (1 to 25 & Above 60 Years)
• Point-of-Care Tests
• Hemoglobin Electrophoresis
• High-performance Liquid Chromatography (HPLC)
Sector Types Covered:
• Corporate Labs
• Government Labs
• Public-Private-Partnerships (PPP)
• Private Labs
• North America
o Rest of Europe
• Asia Pacific
o New Zealand
o Rest of Asia Pacific
• South America
o Rest of South America
• Middle East & Africa
o Saudi Arabia
o South Africa
o Rest of Middle East & Africa
What our report offers:
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2018, 2019, 2020, 2024 and 2027
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic analysis: Drivers and Constraints, Product/Technology Analysis, Porter’s five forces analysis, SWOT analysis, etc.
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements
Free Customization Offerings:
All the customers of this report will be entitled to receive one of the following free customization options:
• Company Profiling
o Comprehensive profiling of additional market players (up to 3)
o SWOT Analysis of key players (up to 3)
• Regional Segmentation
o Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
o Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances
Select License Type
Best in class reports with high standard of research integrity
24X7 Research Support
Continuous support to ensure the best customer experience.
Adding more values to your product of interest.
Safe & Secure Access
Providing a secured environment for all online transactions.
Trusted by 600+ Brands
Serving the most reputed brands across the world.